SARAJEVO (Bosnia and Herzegovina), November 1 (SeeNews) – Bosnian pharmaceuticals producer Bosnalijek [SAJ:BSNLR] said on Wednesday it turned to a net profit of 5.5 million marka ($3.3 million/2.8 million euro) in the first nine months of 2107, from a 3.0 million marka loss a year earlier.
Operating income grew 35.8% to 92.8 million marka in the nine months through September, while operating costs climbed 21.3% to 85.5 million marka, Bosnalijek said in a filing with the Sarajevo Stock Exchange.
In October last year, the government of Bosnia's Federation entity sold its 19.3% stake in Bosnalijek for 23.4 million marka to Malta-based financial services provider KBC Euro Credit Capital.
The Federation is one of the two autonomous entities that make up Bosnia and Herzegovina. The other one is the Serb Republic.
(1 euro=1.95583 Bosnian marka)